Search

everythinglearnresearchcommunity

for

Search:↓

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

675 nm laser therapy effectively improves hair growth in Indian patients with androgenetic alopecia.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

675 nm laser therapy effectively improves hair growth and density in AGA patients.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Vitiligo patients often have other health issues, especially thyroid disorders.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Psoriasis patients have more comorbidities, including autoimmune diseases and other health issues, than those without psoriasis.

Myasthenia gravis can affect both motor and non-motor systems due to immune system issues.

People with Alopecia Areata are more likely to have certain health issues like ulcerative colitis and type 1 diabetes, but less likely to have others like hypertension and type 2 diabetes.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Psoriasis is linked to a higher risk of autoimmune diseases and other health conditions.

People with androgenetic alopecia may have a higher risk of heart problems compared to those with alopecia areata or healthy individuals.

Baricitinib is a promising treatment for alopecia areata.

Psoriasis patients did not show more brain atrophy or small vessel disease than controls, but longer psoriasis duration was linked to more brain atrophy.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Alopecia universalis can be an early sign of HIV.

People with severe alopecia areata often have lower vitamin D levels and may have other autoimmune or allergic conditions.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

People with autism are more likely to develop alopecia areata than those without autism.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.